221 related articles for article (PubMed ID: 11451209)
1. Clinical uses of tumor markers: a critical review.
Duffy MJ
Crit Rev Clin Lab Sci; 2001 Jun; 38(3):225-62. PubMed ID: 11451209
[TBL] [Abstract][Full Text] [Related]
2. Role of tumor markers in patients with solid cancers: A critical review.
Duffy MJ
Eur J Intern Med; 2007 May; 18(3):175-84. PubMed ID: 17449388
[TBL] [Abstract][Full Text] [Related]
3. National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM; Duffy MJ; Stenman UH; Lilja H; Brünner N; Chan DW; Babaian R; Bast RC; Dowell B; Esteva FJ; Haglund C; Harbeck N; Hayes DF; Holten-Andersen M; Klee GG; Lamerz R; Looijenga LH; Molina R; Nielsen HJ; Rittenhouse H; Semjonow A; Shih IeM; Sibley P; Sölétormos G; Stephan C; Sokoll L; Hoffman BR; Diamandis EP;
Clin Chem; 2008 Dec; 54(12):e11-79. PubMed ID: 19042984
[TBL] [Abstract][Full Text] [Related]
4. Tumor markers: value and limitations in the management of cancer patients.
Bates SE; Longo DL
Cancer Treat Rev; 1985 Sep; 12(3):163-207. PubMed ID: 2416441
[TBL] [Abstract][Full Text] [Related]
5. Serum tumor markers.
Perkins GL; Slater ED; Sanders GK; Prichard JG
Am Fam Physician; 2003 Sep; 68(6):1075-82. PubMed ID: 14524394
[TBL] [Abstract][Full Text] [Related]
6. Use of common seric tumor markers in patients with solid cancers.
Gara S; Boussen H; Ghanem A; Guemira F
Tunis Med; 2008 Jun; 86(6):579-83. PubMed ID: 19216452
[TBL] [Abstract][Full Text] [Related]
7. [Clinical usefulness of circulating tumor markers].
Ohkura H
Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
[TBL] [Abstract][Full Text] [Related]
8. Use of Biomarkers in Screening for Cancer.
Duffy MJ
Adv Exp Med Biol; 2015; 867():27-39. PubMed ID: 26530358
[TBL] [Abstract][Full Text] [Related]
9. The Role of Human Chorionic Gonadotropin as Tumor Marker: Biochemical and Clinical Aspects.
Sisinni L; Landriscina M
Adv Exp Med Biol; 2015; 867():159-76. PubMed ID: 26530366
[TBL] [Abstract][Full Text] [Related]
10. Circulating tumor markers and nuclear medicine imaging modalities: breast, prostate and ovarian cancer.
Ugrinska A; Bombardieri E; Stokkel MP; Crippa F; Pauwels EK
Q J Nucl Med; 2002 Jun; 46(2):88-104. PubMed ID: 12114872
[TBL] [Abstract][Full Text] [Related]
11. Tumor markers in breast cancer- European Group on Tumor Markers recommendations.
Molina R; Barak V; van Dalen A; Duffy MJ; Einarsson R; Gion M; Goike H; Lamerz R; Nap M; Sölétormos G; Stieber P
Tumour Biol; 2005; 26(6):281-93. PubMed ID: 16254457
[TBL] [Abstract][Full Text] [Related]
12. Markers supplementing CA 125 in ovarian cancer.
Stenman UH; Alfthan H; Vartiainen J; Lehtovirta P
Ann Med; 1995 Feb; 27(1):115-20. PubMed ID: 7741989
[TBL] [Abstract][Full Text] [Related]
13. Clinical application of tumour markers: a review.
Amayo AA; Kuria JG
East Afr Med J; 2009 Dec; 86(12 Suppl):S76-83. PubMed ID: 21591514
[TBL] [Abstract][Full Text] [Related]
14. Urokinase plasminogen activator: a prognostic marker in multiple types of cancer.
Duffy MJ; Maguire TM; McDermott EW; O'Higgins N
J Surg Oncol; 1999 Jun; 71(2):130-5. PubMed ID: 10389872
[TBL] [Abstract][Full Text] [Related]
15. A personalized approach to cancer treatment: how biomarkers can help.
Duffy MJ; Crown J
Clin Chem; 2008 Nov; 54(11):1770-9. PubMed ID: 18801934
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the clinical use of tumour markers.
Duffy MJ
Ann Clin Biochem; 2004 Sep; 41(Pt 5):370-7. PubMed ID: 15333188
[TBL] [Abstract][Full Text] [Related]
17. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
18. [Biological markers of cancer. Critical study].
Bellet D; Bidart JM
Presse Med; 1993 Apr; 22(14):680-6. PubMed ID: 8511115
[TBL] [Abstract][Full Text] [Related]
19. Placental proteins as tumor markers.
Braunstein GD
Immunol Ser; 1990; 53():673-701. PubMed ID: 1713070
[TBL] [Abstract][Full Text] [Related]
20. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
